Skip to main content
SpringerLink
Log in

Nitrate tolerance

A problem during continuous nitrate administration

  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The organic nitrates are effective agents in the management of patients with angina pectoris. They are the agents of choice in the treatment of acute episodes of angina pectoris and are useful in angina prophylaxis. While the organic nitrates are extremely effective in angina prophylaxis during acute therapy, there is increasing evidence that with many dosing regimens for oral and transdermal therapy, substantial attenuation of the antianginal effects develops. Thus, during acute therapy the organic nitrates improve exercise tolerance for many hours, but during sustained therapy designed to provide antianginal efficacy throughout the 24-h period there is significant attenuation of the beneficial effects. It has been documented that treatment regimens designed to provide a period of nitrate washout prevent or reverse nitrate tolerance, and such changes in dosing regimens have been shown to provide continued antianginal protection. It is clear that the objective of providing 24-h antianginal protection with the organic nitrates cannot be achieved. With appropriate dosing schedules, however, it is possible to improve exercise tolerance throughout the major portion of the 24-h dosing period.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Murrell W (1879) Nitro-glycerine as a remedy for angina pectoris. Lancet I: 80–81

    Google Scholar 

  2. Thadani U, Manyari D, Parker JO, Fung H-L (1980) Tolerance to the circulatory effects of oral isosorbide dinitrate:rate of development and cross-tolerance to glyceryl trinitrate. Circulation 61: 526–535

    PubMed  Google Scholar 

  3. Thadani U, Fung H-L, Darke AC, Parker JO (1982) Oral isosorbide dinitrate in angina pectoris: comparison of duration of action and dose-response relation during acute and sustained therapy. Am J Cardiol 49:411–419

    PubMed  Google Scholar 

  4. Parker JO, VanKoughnett K, Farrell B (1985) Comparison of buccal nitroglycerin and oral isosorbide dinitrate for nitrate tolerance in stable angina pectoris. Am J Cardiol 56: 724–728

    PubMed  Google Scholar 

  5. Parker JO, Farrell B, Lahey KA, Moe G (1987) Effect of intervals between doses on the development of tolerance to isosorbide dinitrate. N Engl J Med 316: 1440–1444

    PubMed  Google Scholar 

  6. Cowan JC, Bourke JP, Reid DS, Julian DG (1987) Prevention of tolerance to nitroglycerin patches by overnight removal. Am J Cardiol 60: 271–275

    PubMed  Google Scholar 

  7. Dargie H, Deanfield J, Fox K, Maseri A (1988) Nitrate tolerance avoided by use of a nitrate-free interval. J Am Coll Cardiol 11: 43 (Abstract)

    Google Scholar 

  8. Packer M, Lee WH, Kessler PD, Gottlieb SS, Medina N, Yushak M (1987) Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med 317: 799–804

    PubMed  Google Scholar 

  9. Parker JO, Farrell B, Lahey KA, Rose BF (1987) Nitrate tolerance: the lack of effect ofN-acetylcysteine. Circulation 76: 572–576

    PubMed  Google Scholar 

  10. Ignarro LJ, Lippton H, Edwards JC et al (1981) Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 218: 739–749

    Google Scholar 

  11. Parker JO, VanKoughnett KA, Fung H-L (1984) Transdermal isosorbide dinitrate in angina pectoris: effect of acute and sustained therapy. Am J Cardiol 54: 8–13

    PubMed  Google Scholar 

  12. Lis Y, Bennett D, Lambert G, Robson D (1984) A preliminary double-blind study of intravenous nitroglycerin in acute myocardial infarction. Intensive Care Med 10: 179–184

    PubMed  Google Scholar 

  13. Brügger W, Imhof P, Willer P, Moser P, Reubi F (1985) Effect of nitroglycerin on blood rheology in healthy subjects. Eur J Clin Pharmacol 29: 331–336

    PubMed  Google Scholar 

  14. Needleman P, Johnson EM Jr (1975) The pharmacological and biochemical interaction of organic nitrates with sulfhydryls: possible correlations with the mechanism for tolerance development, vasodilation and mitochondrial and enzyme reactions. In: Needleman P (ed) Organic nitrates. Springer, Berlin Heidelberg New York, pp 97–114

    Google Scholar 

  15. Torresi J, Horowitz JD, Dusting GJ (1985) Prevention and reversal of tolerance to nitroglycerine withN-acetylcysteine. J Cardiovasc Pharmacol 7: 777–783

    PubMed  Google Scholar 

  16. May DC, Popma JJ, Black WH et al (1987) In vivo induction and reversal of nitroglycerin tolerance in human coronary arteries. N Engl J Med 317: 805–809

    PubMed  Google Scholar 

  17. Fung H-L, Poliszczuk R (1986) Nitrosothiol and nitrate tolerance. Z Kardiol 75 [Suppl 3]: 25–27

    PubMed  Google Scholar 

  18. Waldman SA, Rapoport RM, Ginsburg R, Murad F (1986) Desensitization to nitroglycerin in vascular smooth muscle from rat and human. Biochem Pharmacol 35: 3525–3531

    PubMed  Google Scholar 

  19. Kala R, Hirvonen P, Gordin A, Sundberg S, Auvinen J, Halonen PI (1983) Nitroglycerin ointment effective for seven hours in severe angina pectoris. Acta Med Scand 213: 165–170

    PubMed  Google Scholar 

  20. Thompson RH (1983) The clinical use of transdermal delivery devices with nitroglycerin. Angiology 34: 23–31

    PubMed  Google Scholar 

  21. Parker JO, Fung H-L (1984) Transdermal nitroglycerin in angina pectoris. Am J Cardiol 54: 471–476

    PubMed  Google Scholar 

  22. Reichek N, Priest C, Zimrin D, Chandler T, Sutton MSTJ (1984) Antianginal effects of nitroglycerin patches. Am J Cardiol 54: 1–7

    PubMed  Google Scholar 

  23. Thadani U, Hamilton SF, Olson E et al (1986) Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance. Ann Intern Med 105: 485–492

    PubMed  Google Scholar 

  24. Zimrin D, Reichek N, Bogin KT et al (1988) Antianginal effects of intravenous nitroglycerin over 24 hours. Circulation 77: 1376–1384

    PubMed  Google Scholar 

  25. Elkayam U, Kulick D, McIntosh N, Roth A, Hsueh W, Rahimtoola SH (1987) Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure. Circulation 76: 577–584

    PubMed  Google Scholar 

  26. Packer M, Gottlieb SS, Kessler PD et al (1988) Overnight withdrawal of nitroglycerin therapy does not prevent the development of nitrate tolerance in severe heart failure. J Am Coll Cardiol 11: 43A (Abstract)

  27. Thadani U, Sharma M, Thompson D, Prasad R, Goli V, Corn C (1987) Intravenous nitroglycerin and tolerance in unstable angina. Circulation 76 [Suppl 4]: IV-128 (Abstract 508)

    Google Scholar 

  28. Jordan RA, Seth L, Henry A, Wilen MM, Franciosa JA (1985) Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure. Circulation 71: 980–986

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology Department of Medicine, Queen's University, Etherington Hall Stuart Street, K7L 3N6, Kingston, Ontario, Canada

    J. O. Parker

Authors
  1. J. O. Parker
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parker, J.O. Nitrate tolerance. Eur J Clin Pharmacol 38 (Suppl 1), S21–S25 (1990). https://doi.org/10.1007/BF01417561

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01417561

Key words

Search

Navigation